Drug Repurposing for the Treatment of Acute Myeloid Leukemia by Vibeke Andresen, Bjørn T. Gjertsen, Bjørn T. Gjertsen

Get full text

Colony Stimulating Factor 1 Receptor in Acute Myeloid Leukemia by Kristine Yttersian Sletta, Oriol Castells, Bjørn Tore Gjertsen, Bjørn Tore Gjertsen

Get full text

Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling by Daniele Mercatelli, Daniele Mercatelli, Massimo Bortolotti, Vibeke Andresen, Vibeke Andresen, André Sulen, Letizia Polito, Bjørn Tore Gjertsen, Bjørn Tore Gjertsen, Andrea Bolognesi

Get full text

Early response evaluation in AML using mass cytometry by Bjørn T. Gjertsen, Benedicte S. Tislevoll, Oda H.E. Fagerholt, Monica Hellesøy

Get full text

Single Cell Detection of the p53 Protein by Mass Cytometry by Oda Helen Eck Fagerholt, Monica Hellesøy, Stein-Erik Gullaksen, Bjørn Tore Gjertsen

Get full text

Favorable outcome of a patient with an unclassifiable myelodysplastic syndrome/myeloproliferative neoplasm treated with allogeneic hematopoietic stem cell transplantation by Anette Lodvir Hemsing, Bjørn Tore Gjertsen, Signe Spetalen, Lars Helgeland, Håkon Reikvam

Get full text

Systemic Metabolomic Profiling of Acute Myeloid Leukemia Patients before and During Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid, Valproic Acid, and Low-Dose Chem... by Ida Sofie Grønningsæter, Hanne Kristin Fredly, Bjørn Tore Gjertsen, Kimberley Joanne Hatfield, Øystein Bruserud

Get full text

Sex disparity in acute myeloid leukaemia with FLT3 internal tandem duplication mutations: implications for prognosis by Monica Hellesøy, Caroline Engen, Tim Grob, Bob Löwenberg, Peter J. M. Valk, Bjørn T. Gjertsen

Get full text

The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer. by Øystein Helland, Mihaela Popa, Katharina Bischof, Bjørn Tore Gjertsen, Emmet McCormack, Line Bjørge

Get full text

Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century by Kari Hemminki, Frantisek Zitricky, Asta Försti, Mika Kontro, Bjorn T. Gjertsen, Marianne Tang Severinsen, Gunnar Juliusson

Get full text

Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia – identification of responders by gene expression profiling of pretreatme... by Håkon Reikvam, Randi Hovland, Rakel Brendsdal Forthun, Sigrid Erdal, Bjørn Tore Gjertsen, Hanne Fredly, Øystein Bruserud

Get full text

A Comparison of p53 Isoform Profiles and Apoptosis Induced by Camptothecin or a Herbal Khat Extract (<i>Catha Edulis (Vahl) Forssk. ex Endl.</i>) in Leukemic Cell Lines: Exploring... by Therese Bredholt Onyango, Sigrun M. Hjelle, Ingvild Haaland, Olav K. Vintermyr, Anne Christine Johannessen, Bjørn Tore Gjertsen

Get full text

First in-mouse development and application of a surgically relevant xenograft model of ovarian carcinoma. by Oystein Helland, Mihaela Popa, Olav K Vintermyr, Anders Molven, Bjørn Tore Gjertsen, Line Bjørge, Emmet McCormack

Get full text

Intracellular Signaling in Key Pathways Is Induced by Treatment with Ultrasound and Microbubbles in a Leukemia Cell Line, but Not in Healthy Peripheral Blood Mononuclear Cells by Ragnhild Haugse, Anika Langer, Stein-Erik Gullaksen, Silje Maria Sundøy, Bjørn Tore Gjertsen, Spiros Kotopoulis, Emmet McCormack

Get full text

p53 Protein Isoform Profiles in AML: Correlation with Distinct Differentiation Stages and Response to Epigenetic Differentiation Therapy by Ingvild Haaland, Sigrun M. Hjelle, Håkon Reikvam, André Sulen, Anita Ryningen, Emmet McCormack, Øystein Bruserud, Bjørn Tore Gjertsen

Get full text

Enhanced T-lymphocyte infiltration in a desmoid tumor of the thoracic wall in a young woman treated with intratumoral injections of the oncolytic peptide LTX-315: a case report by Nina Louise Jebsen, Torunn Oveland Apelseth, Hans Kristian Haugland, Øystein Rekdal, Hamina Patel, Bjørn Tore Gjertsen, Dag Eirik Jøssang

Get full text

Cross-species functional genomic analysis identifies resistance genes of the histone deacetylase inhibitor valproic acid. by Rakel Brendsdal Forthun, Tanima Sengupta, Hanne Kim Skjeldam, Jessica Margareta Lindvall, Emmet McCormack, Bjørn Tore Gjertsen, Hilde Nilsen

Get full text

Deficient phosphorylation of Stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-beta. by Sonia Gavasso, Ellen Faergestad Mosleth, Tove Marøy, Katarina Jørgensen, Hanne-Linda Nakkestad, Bjørn-Tore Gjertsen, Kjell-Morten Myhr, Christian Vedeler

Get full text

Philadelphia chromosome positive AML arising from JAK2-positive myelofibrosis by Marte Karen Brattås, Kyrre Lilleeng, Randi Hovland, Ingvild Jenssen Lægreid, Marta Vorland, Friedemann Leh, Øystein Bruserud, Bjørn Tore Gjertsen, Håkon Reikvam

Get full text

Increased Plasma Colloid Osmotic Pressure Facilitates the Uptake of Therapeutic Macromolecules in a Xenograft Tumor Model by Matthias Hofmann, Emmet McCormack, Maja Mujic, Maila Roßberg, August Bernd, Jürgen Bereiter-Hahn, Bjørn Tore Gjertsen, Helge Wiig, Stefan Kippenberger

Get full text